University of Indonesia
Depok, West Java, 16424, Indonesia
NCT Number: NCT03469869
This study evaluates the effect of balanced and sustainable diet application on fat composition, insulin resistance and inflammation marker in obese people.
Intervention: Obese subject will receive intervention on balanced and sustainable diet application Control: Obese subject will receive a balanced diet application only
Looking for future studies?
Notify Me19 year–59 year
Female
Interventional
Not applicable
Depok, West Java, 16424, Indonesia
Maintaining the adherence of weight loss programme while selecting healthy and sustainable foods will become a worldwide future challenge in nutrition. Therefore, we investigated the suitable content, graphic, and flow in developing a mobile application as an alternative solution for enhancing the compliance of weight control and selecting healthy food with the least environmental impact.
The treatment for obesity consists of dieting, physical exercise, pharmacology, and surgery. Restricted balanced diet is a well known diet recommendation for people with obesity. Sustainable diet is an alternative form of diet which contributes to healthy life and is protective of biodiversity.
The main challenge in obesity management is the sustainability of weight loss programme. Mobile apps are an alternative solution for enhancing compliance.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp.
the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp.
Time frame: baseline at Day0 and endline at Day56
Change from baseline body weight at 8 weeks, is measured in kg
Time frame: baseline at Day0 and endline at Day56
Change from baseline Fat Mass at 8 weeks, is measured by body composition analyzer in kg
Time frame: baseline at Day0 and endline at Day56
Change from baseline Fasting plasma glucose at 8 weeks, is measured in mg/dL
Time frame: baseline at Day0 and endline at Day56
Change from baseline TNF alpha at 8 weeks, is measured in pg/ml
Time frame: baseline at Day0 and endline at Day56
Change from baseline Fasting Insulin at 8 weeks, is measured in µU/mL
Time frame: baseline at Day0 and endline at Day56
Change from baseline HOMA-IR at 8 weeks, is measured using formulation : glukosa (mg/dL) x insulin (µU/mL)/405
Time frame: baseline at Day0 and endline at Day56
Change from baseline Waist Circumference at 8 weeks, is measured in cm
Time frame: baseline at Day0 and endline at Day56
Change from baseline Carbohydrate intake at 8 weeks, is measured in gram using 24HR-recall
Time frame: baseline at Day0 and endline at Day56
Change from baseline Fat intake at 8 weeks, is measured in gram using 24HR-recall
Time frame: baseline at Day0 and endline at Day56
Change from baseline Protein intake at 8 weeks, is measured in gram using 24HR-recall
Indonesia University
Other
The Effect of Balanced and Sustainable Diet for Insulin Resistance and Inflammation Marker of Obese Adults in Indonesia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07241741
Body Weight, C-reactive Protein
View Trial DetailsNCT05295719
Body Weight, Dyslipidemias
Lubbock, Texas, United States
View Trial DetailsNCT05017571
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT06242535
Behavior, Behavioral Symptoms
Gillette, Wyoming, United States
View Trial Details